Items where Author is "Bobos, Mattheos"

Kotoula, Vassiliki and Tsakiri, Kalliopi and Koliou, Georgia-Angeliki and Lazaridis, Georgios and Papadopoulou, Kyriaki and Giannoulatou, Eleni and Tikas, Ioannis and Christodoulou, Christos and Chatzopoulos, Kyriakos and Bobos, Mattheos and Pentheroudakis, George and Tsolaki, Eleftheria and Batistatou, Anna and Kotsakis, Athanassios and Koutras, Angelos and Linardou, Helena and Razis, Evangelia and Res, Eleni and Pectasides, Dimitrios and Fountzilas, George (2018) Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome. Clinical Breast Cancer, ePub. ISSN 1526-8209 (Not OA)

Papaxoinis, George and Kotoula, Vassiliki and Giannoulatou, Eleni and Koliou, Georgia-Angeliki and Karavasilis, Vasilios and Lakis, Sotirios and Koureas, Andreas and Bobos, Mattheos and Chalaralambous, Elpida and Daskalaki, Emily and Chatzopoulos, Kyriakos and Tsironis, George and Pazarli, Elisavet and Chrisafi, Sofia and Samantas, Epaminontas and Kaklamanos, Ioannis G. and Varthalitis, Ioannis and Konstantara, Athina and Syrigos, Konstantinos N. and Pentheroudakis, George and Pectasides, Dimitrios and Fountzilas, George (2018) Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping. Medical Oncology, 35 (7). p. 101. ISSN 1357-0560 (Not OA)

Fountzilas, George and Psyrri, Amanda and Giannoulatou, Eleni and Tikas, Ioannis and Manousou, Kyriaki and Rontogianni, Dimitra and Ciuleanu, Elisabeta and Ciuleanu, Tudor and Resiga, Liliana and Zaramboukas, Thomas and Papadopoulou, Kyriaki and Bobos, Mattheos and Chrisafi, Sofia and Tsolaki, Eleftheria and Markou, Konstantinos and Giotakis, Evangelos and Koutras, Angelos and Psoma, Elsa and Kalogera-Fountzila, Anna and Skondra, Maria and Bamia, Christina and Pectasides, Dimitrios and Kotoula, Vassiliki (2018) Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe. International Journal of Cancer, 142 (1). pp.66-80. ISSN 00207136 (Not OA)

Fountzilas, Elena and Kotoula, Vassiliki and Zagouri, Flora and Giannoulatou, Eleni and Kouvatseas, George and Pentheroudakis, George and Koletsa, Triantafyllia and Bobos, Mattheos and Papadopoulou, Kyriaki and Samantas, Epaminontas and Demiri, Efterpi and Miliaras, Spyros and Christodoulou, Christos and Chrisafi, Sofia and Razis, Evangelia and Fostira, Florentia and Pectasides, Dimitrios and Zografos, George and Fountzilas, George (2016) Disease evolution and heterogeneity in bilateral breast cancer. American Journal of Cancer Research, 6 (11). pp.2611-2630. ISSN 2156-6976 (PMC OA)

Kotoula, Vassiliki and Karavasilis, Vasilios and Zagouri, Flora and Kouvatseas, George and Giannoulatou, Eleni and Gogas, Helen and Lakis, Sotiris and Pentheroudakis, George and Bobos, Mattheos and Papadopoulou, Kyriaki and Tsolaki, Eleftheria and Pectasides, Dimitrios and Lazaridis, Georgios and Koutras, Angelos and Aravantinos, Gerasimos and Christodoulou, Christos and Papakostas, Pavlos and Markopoulos, Christos and Zografos, George and Papandreou, Christos and Fountzilas, George (2016) Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes. Breast Cancer Research and Treatment, 158 (2). pp.307-321. ISSN 1573-7217 (PP OA)

Fountzilas, George and Giannoulatou, Eleni and Alexopoulou, Zoi and Zagouri, Flora and Timotheadou, Eleni and Papadopoulou, Kyriaki and Lakis, Sotiris and Bobos, Mattheos and Poulios, Christos and Sotiropoulou, Maria and Lyberopoulou, Aggeliki and Gogas, Helen and Pentheroudakis, George and Pectasides, Dimitrios and Koutras, Angelos and Christodoulou, Christos and Papandreou, Christos and Samantas, Epaminontas and Papakostas, Pavlos and Kosmidis, Paris and Bafaloukos, Dimitrios and Karanikiotis, Charisios and Dimopoulos, Meletios-Athanassios and Kotoula, Vassiliki (2016) TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting. Oncotarget, 7 (22). pp.32731-32753. ISSN 1949-2553 (OA)